These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33367731)

  • 1. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
    Strich JR; Ramos-Benitez MJ; Randazzo D; Stein SR; Babyak A; Davey RT; Suffredini AF; Childs RW; Chertow DS
    J Infect Dis; 2021 Mar; 223(6):981-984. PubMed ID: 33367731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R406 reduces lipopolysaccharide-induced neutrophil activation.
    Warner S; Teague HL; Ramos-Benitez MJ; Panicker S; Allen K; Gairhe S; Moyer T; Parachalil Gopalan B; Douagi I; Shet A; Kanthi Y; Suffredini AF; Chertow DS; Strich JR
    Cell Immunol; 2024; 403-404():104860. PubMed ID: 39084187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial.
    Strich JR; Tian X; Samour M; King CS; Shlobin O; Reger R; Cohen J; Ahmad K; Brown AW; Khangoora V; Aryal S; Migdady Y; Kyte JJ; Joo J; Hays R; Collins AC; Battle E; Valdez J; Rivero J; Kim IH; Erb-Alvarez J; Shalhoub R; Chakraborty M; Wong S; Colton B; Ramos-Benitez MJ; Warner S; Chertow DS; Olivier KN; Aue G; Davey RT; Suffredini AF; Childs RW; Nathan SD
    Clin Infect Dis; 2022 Aug; 75(1):e491-e498. PubMed ID: 34467402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
    Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Cremonesi G; Khan A; Mantelli F; Allegretti M; Balk R
    Eur J Immunol; 2023 Jan; 53(1):e2250010. PubMed ID: 36239164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.
    Bautista-Becerril B; Campi-Caballero R; Sevilla-Fuentes S; Hernández-Regino LM; Hanono A; Flores-Bustamante A; González-Flores J; García-Ávila CA; Aquino-Gálvez A; Castillejos-López M; Juárez-Cisneros A; Camarena A
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34066385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients.
    Zhang Y; Han K; Du C; Li R; Liu J; Zeng H; Zhu L; Li A
    Crit Care; 2021 Feb; 25(1):51. PubMed ID: 33557911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.
    Szturmowicz M; Demkow U
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs.
    Harbi MH; Smith CW; Alenazy FO; Nicolson PLR; Tiwari A; Watson SP; Thomas MR
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils during SARS-CoV-2 infection: Friend or foe?
    Castanheira FVS; Kubes P
    Immunol Rev; 2023 Mar; 314(1):399-412. PubMed ID: 36440642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model.
    Veras FP; Gomes GF; Silva BMS; Caetité DB; Almeida CJLR; Silva CMS; Schneider AH; Corneo ES; Bonilha CS; Batah SS; Martins R; Arruda E; Fabro AT; Alves-Filho JC; Cunha TM; Cunha FQ
    Respir Res; 2023 Mar; 24(1):66. PubMed ID: 36864506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with COVID-19: in the dark-NETs of neutrophils.
    Ackermann M; Anders HJ; Bilyy R; Bowlin GL; Daniel C; De Lorenzo R; Egeblad M; Henneck T; Hidalgo A; Hoffmann M; Hohberger B; Kanthi Y; Kaplan MJ; Knight JS; Knopf J; Kolaczkowska E; Kubes P; Leppkes M; Mahajan A; Manfredi AA; Maueröder C; Maugeri N; Mitroulis I; Muñoz LE; Narasaraju T; Naschberger E; Neeli I; Ng LG; Radic MZ; Ritis K; Rovere-Querini P; Schapher M; Schauer C; Simon HU; Singh J; Skendros P; Stark K; Stürzl M; van der Vlag J; Vandenabeele P; Vitkov L; von Köckritz-Blickwede M; Yanginlar C; Yousefi S; Zarbock A; Schett G; Herrmann M
    Cell Death Differ; 2021 Nov; 28(11):3125-3139. PubMed ID: 34031543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells.
    Platt AM; Benson RA; McQueenie R; Butcher JP; Braddock M; Brewer JM; McInnes IB; Garside P
    Rheumatology (Oxford); 2015 Jan; 54(1):169-77. PubMed ID: 25065010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
    Schönrich G; Raftery MJ; Samstag Y
    Adv Biol Regul; 2020 Aug; 77():100741. PubMed ID: 32773102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils in COVID-19: recent insights and advances.
    Li J; Zhang K; Zhang Y; Gu Z; Huang C
    Virol J; 2023 Aug; 20(1):169. PubMed ID: 37533131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
    Skendros P; Mitsios A; Chrysanthopoulou A; Mastellos DC; Metallidis S; Rafailidis P; Ntinopoulou M; Sertaridou E; Tsironidou V; Tsigalou C; Tektonidou M; Konstantinidis T; Papagoras C; Mitroulis I; Germanidis G; Lambris JD; Ritis K
    J Clin Invest; 2020 Nov; 130(11):6151-6157. PubMed ID: 32759504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?
    Kalyanaraman B
    Redox Biol; 2020 Oct; 37():101721. PubMed ID: 32961440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
    Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Bose D; Basu S
    Methods; 2022 Jul; 203():564-574. PubMed ID: 34455072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.